


The main goal of this project is to investigate whether the oncologic outcome in patients with post-prostatectomy recurrent PCa can be improved, by increasing the biological effective radiation dose using a hypofractionated schedule of 20 x 3 = 60 Gy. sEBRT can provide long-term disease control with 5 year biochemical progression-free survival (bPFS) up to 60% and with most treatment failures in the first 2 years after sEBRT.

The standard treatment of post-prostatectomy BR is salvage external beam radiation therapy (sEBRT). Why Should I Register and Submit Results?Īfter radical prostatectomy approximately 15-40% of men develop a biochemical recurrence (BR) within 5 years.
